Declan Doogan - Net Worth and Insider Trading

Declan Doogan Net Worth

The estimated net worth of Declan Doogan is at least $21 Million dollars as of 2024-11-13. Declan Doogan is the Director of Biohaven Pharmaceutical Holding Co Ltd and owns about 1,496,650 shares of Biohaven Pharmaceutical Holding Co Ltd (BHVN) stock worth over $21 Million. Details can be seen in Declan Doogan's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Declan Doogan has not made any transactions after 2021-11-29 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Declan Doogan

To

Declan Doogan Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Declan Doogan owns 2 companies in total, including Biohaven Pharmaceutical Holding Co Ltd (BHVN) , and Tenax Therapeutics Inc (TENX) .

Click here to see the complete history of Declan Doogan’s form 4 insider trades.

Insider Ownership Summary of Declan Doogan

Ticker Comapny Transaction Date Type of Owner
BHVN Biohaven Pharmaceutical Holding Co Ltd 2021-11-29 director
TENX Tenax Therapeutics Inc 2021-02-25 director

Declan Doogan Latest Holdings Summary

Declan Doogan currently owns a total of 1 stock. Declan Doogan owns 1,496,650 shares of Biohaven Pharmaceutical Holding Co Ltd (BHVN) as of November 29, 2021, with a value of $21 Million.

Latest Holdings of Declan Doogan

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
BHVN Biohaven Pharmaceutical Holding Co Ltd 2021-11-29 1,496,650 14.08 21,072,832

Holding Weightings of Declan Doogan


Declan Doogan Form 4 Trading Tracker

According to the SEC Form 4 filings, Declan Doogan has made a total of 6 transactions in Biohaven Pharmaceutical Holding Co Ltd (BHVN) over the past 5 years, including 0 buys and 6 sells. The most-recent trade in Biohaven Pharmaceutical Holding Co Ltd is the sale of 24,525 shares on November 29, 2021, which brought Declan Doogan around $3 Million.

Insider Trading History of Declan Doogan

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Declan Doogan Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Declan Doogan Ownership Network

Ownership Network List of Declan Doogan

No Data

Ownership Network Relation of Declan Doogan

Insider Network Chart

Declan Doogan Owned Company Details

What does Biohaven Pharmaceutical Holding Co Ltd do?

Who are the key executives at Biohaven Pharmaceutical Holding Co Ltd?

Declan Doogan is the director of Biohaven Pharmaceutical Holding Co Ltd. Other key executives at Biohaven Pharmaceutical Holding Co Ltd include VP & Chief Accounting Officer George C. Clark , Chief Medical Officer Elyse Stock , and Chief Financial Officer James Engelhart .

Biohaven Pharmaceutical Holding Co Ltd (BHVN) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Biohaven Pharmaceutical Holding Co Ltd (BHVN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Biohaven Pharmaceutical Holding Co Ltd (BHVN) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Biohaven Pharmaceutical Holding Co Ltd (BHVN)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Biohaven Pharmaceutical Holding Co Ltd Insider Transactions

No Available Data

Declan Doogan Mailing Address

Above is the net worth, insider trading, and ownership report for Declan Doogan. You might contact Declan Doogan via mailing address: C/o Biohaven Pharmaceutical Holding Comp, 234 Church Street, New Haven Ct 06510.